Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes

Background Organic cation transporter 1 primarily governs the action of metformin in the liver. There are considerable inter-individual variations in metformin response. In light of this, it is crucial to obtain a greater understanding of the influence of OCT1 expression or polymorphism in the conte...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC endocrine disorders Jg. 22; H. 1; S. 140 - 11
Hauptverfasser:	Kawoosa, Fizalah, Shah, Zafar A., Masoodi, Shariq R., Amin, Asif, Rasool, Roohi, Fazili, Khalid M., Dar, Abid Hamid, Lone, Asif, ul Bashir, Samir
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 26.05.2022 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	AMPK Antidiabetics Care and treatment Cluster analysis Diabetes Diabetes mellitus (non-insulin dependent) Endocrinology Ethylenediaminetetraacetic acid Gene expression Genetic aspects Genetic diversity Genotyping Hypoglycemic agents Ligands Liver Medicine Medicine & Public Health Metabolic Diseases Metformin Monoclonal antibodies Mutagenesis Oct-1 protein Organic cation transporter Organic cation transporter 1(OCT-1/SLC22A1) Patients Proteins RNA rology Simulation Single-nucleotide polymorphism Type 2 diabetes India United States > US AMPK Organic cation transporter 1(OCT-1/SLC22A1) Metformin
ISSN:	1472-6823, 1472-6823
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!